TBRG · TruBridge, Inc.
Price & Indicators
Up next
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders NeutralIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted EBITDA non-GAAP | 16.5M | Q1 2026 | -9.5% |
|
|
|||
| Non-GAAP net income non-GAAP | 8.5M | Q1 2026 | — |
|
|
|||
| Recurring revenue | 94% | Q1 2026 | — |
|
|
|||
| Total bookings | 17.7M | Q1 2026 | — |
|
|
|||
| Financial Health revenue | $221.7M | Full Year 2025 | — |
| Financial Health revenue % of total revenue | 64% | Full Year 2025 | — |
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Health Information Services — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
TBRG
this stock
TruBridge, Inc.
|
$393.58M | — | +3.2% | 90.5 | 3.7% |
|
VEEV
Veeva Systems Inc
|
$34.68B | -4.4% | +28.1% | 37.9 | 4.9% |
|
PMDIY
Pro Medicus Ltd./ADR
|
$15.41B | -10.9% | — | — | 0.0% |
|
BTSG
BrightSpring Health Services, Inc.
|
$11.99B | +68.3% | -23.6% | 36.7 | 5.0% |
|
HQY
Healthequity, Inc.
|
$8.73B | +14.0% | +28.7% | 39.1 | 6.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| TBRG | — | — | — | — | — |
| SPY | -0.3% | +1.6% | +8.3% | +0.3% | +9.9% |
| vs SPY | — | — | — | — | — |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.